8-7016700-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_005217.4(DEFA3):​c.151G>A​(p.Glu51Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000016 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

DEFA3
NM_005217.4 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.432
Variant links:
Genes affected
DEFA3 (HGNC:2762): (defensin alpha 3) Defensins are a family of antimicrobial and cytotoxic peptides thought to be involved in host defense. They are abundant in the granules of neutrophils and also found in the epithelia of mucosal surfaces such as those of the intestine, respiratory tract, urinary tract, and vagina. Members of the defensin family are highly similar in protein sequence and distinguished by a conserved cysteine motif. The protein encoded by this gene, defensin, alpha 3, is found in the microbicidal granules of neutrophils and likely plays a role in phagocyte-mediated host defense. Several alpha defensin genes are clustered on chromosome 8. This gene differs from defensin, alpha 1 by only one amino acid. This gene and the gene encoding defensin, alpha 1 are both subject to copy number variation. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.067493826).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DEFA3NM_005217.4 linkuse as main transcriptc.151G>A p.Glu51Lys missense_variant 2/3 ENST00000327857.7 NP_005208.1 P59666Q6EZE9
DEFA3XM_011534741.3 linkuse as main transcriptc.172G>A p.Glu58Lys missense_variant 3/4 XP_011533043.1
LOC124901875XR_007060790.1 linkuse as main transcriptn.228C>T non_coding_transcript_exon_variant 2/2
LOC124901875XR_007060791.1 linkuse as main transcriptn.381C>T non_coding_transcript_exon_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DEFA3ENST00000327857.7 linkuse as main transcriptc.151G>A p.Glu51Lys missense_variant 2/31 NM_005217.4 ENSP00000328359.2 P59666

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
4
AN:
146618
Hom.:
0
Cov.:
27
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000688
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.000510
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000161
AC:
21
AN:
1307218
Hom.:
0
Cov.:
27
AF XY:
0.0000154
AC XY:
10
AN XY:
648456
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000212
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000276
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000896
Gnomad4 OTH exome
AF:
0.0000551
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000273
AC:
4
AN:
146618
Hom.:
0
Cov.:
27
AF XY:
0.0000280
AC XY:
2
AN XY:
71498
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000688
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000151
Gnomad4 OTH
AF:
0.000510

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 29, 2024The c.151G>A (p.E51K) alteration is located in exon 2 (coding exon 1) of the DEFA3 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the glutamic acid (E) at amino acid position 51 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
2.0
DANN
Benign
0.88
DEOGEN2
Benign
0.029
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0034
N
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.0013
T
MetaRNN
Benign
0.067
T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.2
N
REVEL
Benign
0.026
Sift
Benign
0.21
T
Sift4G
Benign
0.22
T
Polyphen
0.0
B
Vest4
0.084
MutPred
0.49
Gain of methylation at E51 (P = 0.0071);
MVP
0.18
MPC
1.8
ClinPred
0.069
T
GERP RS
1.1
Varity_R
0.048
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1228189820; hg19: chr8-6874222; COSMIC: COSV100590647; API